HIV prevalence among pulmonary tuberculosis patients in Guangxi, China

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue SUPPL. 1, 2010, Pages

  Wang, Liyan ^a   Liu, Wei ^b   Wang, Lu ^a   Wang, Yan ^c   Wu, Zunyou ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

China; Coinfection; HIV; Tuberculosis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINA; CLUSTER ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RURAL AREA; URBAN AREA;

ADOLESCENT; ADULT; AGED; CHINA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 75749147072     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c7db2e     Document Type: Article

References (29)

1. Barnes PF, Block AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324: 1644-1650
2. U.S. Centers for Disease Control and Prevention. Tuberculosis and Human Immunodeficiency Virus Infection: Recommendations of the Advisory Committee for Elimination of Tuberculosis (ACET). MMWR; 1989;38:236-238, 243-250
3. Anti tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Antituberculosis Surveillance. Geneva, Switzerland: WHO/ TB/97 1997.
4. The World Health Organization. Anti Tuberculosis Drug Resistance in the World Report No.2.-Prevalence and Trends. The WHO/IUATLD Global Project on Antituberculosis Surveillance. WHO/CDS/TB/2000.278. Geneva, Switzerland 2000.
5. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res. 2004;120:277-289.
6. World Health Organization. TB/HIV research priorities in resource-limited settings. Geneva, Switzerland: WHO; 2005.
7. Ai W. An overview of the studies on HIV/AIDS and Tuberculosis co-infection. Int Med Chin. 2007;2:604-606.
8. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-1021.
9. National tuberculosis epidemiology sample survey office. The report of national tuberculosis sampling epidemiology survey. J Chin Antituber-culosis Assoc. 2002;24:65-67.
10. Wu G, Gong Y, Li Y, et al. A study of the effect of TB control programs on disease burden. Chin J Hosp Admin. 2001;17:717-720
11. State Council AIDS Working Committee Office, UN Theme Group on HIV/AIDS in China. A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China (2007). State Council AIDS Working Committee Office; Beijing, China 2007.
12. Chinese Center for Disease Control and Prevention. Incidence and Death Report of Notifiable Infectious Disease in China, in 2006. Chinese Center for Disease Control and Prevention, Beijing, China 2006.
13. World Health Organization. Guidelines for HIV Surveillance Among Tuberculosis Patients. 2nd ed. Geneva, Switzerland: World Health Organization; 2004.
14. Wang L, Ma J, Xing Y. The Changing trend and characteristics of rural resident's needs and demands of health service: one of the reports about studies between situation of rural resident's needs and supply of health service and strategy on the resources arrangement. Chinese Health Economics Magazine. 2004;123:21-24.
15. Dong F, Geng W. Basic siltuation and influence factor of implementation on tuberculosis DOTS strategy in Guangxi. J Chin Mod Med. 2007;4: 598-1201.
16. Zhu Q, Liu W, Chen J, et al. Analysis of data of AIDS sentinel surveillance from 1996 to 2003 in Guangxi province. Chin J AIDS STD. 2006;12: 429-432
17. Chinese Ministry of Health. The standards of Infectious Diseases diagnosis prescribed in Law of the PRC on the Prevention and Treatment of Infectious Diseases (for trial implementation), Beijing, China 1990.
18. Chinese Center for Disease Control and Prevention. Chinese National Guideline for Detection of HIV/AIDS (2004 version). Beijing, China 2004.
19. Daniel OJ, Ogunfowora OB, Oladapo OT. HIV sero-prevalence among children diagnosed with TB in Nigeria. Trop Doct. 2007;37: 268-269
20. USAID. USAID's work on tuberculosis in Tanzania 2005. Available at http://www.usaid.gov/our-work/global-health/id/tuberculosis/countries/ africa/tanzania-profile.html. Accessed October 05, 2008.
21. Trinh TT, Shah NS, Mai HA, et al. HIV-associated TB in An Giang Province, Vietnam, 2001-2004: epidemiology and TB treatment outcomes. PLoS ONE. 2007;2:e507.
22. Tran NB, Rein MGJH, Hoang TQ, et al. HIV and Tuberculosis in Ho Chi Minh city, Vietnam, 1997-2002. Emerg Infect Dis. 2007. Available at: http://www.cdc.gov/eid/content/13/10/pdfs/1463.pdf. Accessed on March 10, 2008.
23. Liu F, Ou-Yang H. HIV Prevalence Survey among Tuberculosis Patients in Hunan province. Pract Prev Med. 2005;12:115.
24. Zeng X. Primary analysis of HIV infection in patients with pulmonary tuberculosis. Chinese J AIDS/STD. 2004;10:354-355.
25. Lu L, Zhang L, Yuan S. Research on cooperation mode between TB/HIV infection prevention and control organizations. Med Anti Prev. 2008;24: 100-101.
26. Yang Y, Fang E, Xun S. Surveillance method investigation on HIV/TB coinfection. J Clin Exp Med. 2007;6:105.
27. Henderson RH, Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Org. 1982;60:253-260.
28. Lemeshow S, Robinson D. Surveys to measure program coverage and impact: a review of the methodology used by the expanded Program on Immunization. World Health Stat Q. 1985;38:65-75.
29. Range N, Magnussen P, Mugomela A, et al. HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol. 2007;101:343-351